Researchers world-wide are focused on clearing the toxic mutant Huntingtin protein that leads to neuronal cell death and systemic dysfunction in Huntingtons disease (HD), a devastating, incurable, progressive neurodegenerative genetic disorder. Scientists in the Buck Institutes Ellerby lab have found that the targeting the protein called FK506-binding protein 51 or FKBP51 promotes the clearing of those toxic proteins via autophagy, a natural process whereby cells recycle damaged proteins and mitochondria and use them for nutrition.
- Read more about Path breaking research in Huntingtons disease rapamycin target protein
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/path-breaking-research-in-huntingtons-disease-rapamycin-target-protein
No comments:
Post a Comment